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Abstract 
We report maximized specific loss power and intrinsic loss power approaching 
theoretical limits for AC magnetic field heating of nanoparticles. This is achieved by 
engineering the effective magnetic anisotropy barrier of nanoparticles via alloying of 
hard and soft ferrites. 22 nm Co0.03Mn0.28Fe2.7O4/SiO2 NPs reached a specific loss 
power value of 3417 W/gmetal at a field of 33 kA/m and 380 kHz.  Biocompatible 
Zn0.3Fe2.7O4/SiO2 nanoparticles achieved specific loss power of 500 W/gmetal and 
intrinsic loss power of 26.8 nHm2/kg at field parameters of 7 kA/m and 380 kHz, below 
the clinical safety limit. Magnetic bone cement achieved heating adequate for bone 
tumor hyperthermia, incorporating ultralow dosage of just 1 wt% of nanoparticles. In 
cellular hyperthermia experiments, these nanoparticles demonstrated high cell death 
rate at low field parameters. Zn0.3Fe2.7O4/SiO2 nanoparticles show cell viabilities above 
97% at concentrations up to 500 µg/ml within 48 hrs, suggesting toxicity lower than 
that of magnetite. 
Keywords: magnetic nanoparticles, magnetic hyperthermia, specific loss power, 
intrinsic loss power, magnetic anisotropy  
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Magnetic nanoparticles (NPs) have received great attention over the past several 
decades due to their potential biomedical applications in targeted drug delivery, 
biological separation, magnetoresistive bio-sensing, magnetic resonance imaging, and 
as heat dissipation agents in gene transcription, neural stimulation and cancer 
treatment.[1-12] Magnetic hyperthermia, first proposed by Gilchrist in 1957,[13] employs 
heat dissipation by magnetic NPs in an alternating current (AC) magnetic field to kill 
tumor cells. The design and synthesis of magnetic NPs should take into consideration 
the following constraints: first of all, they should have the highest possible specific loss 
power (SLP) within the field and frequency range deemed safe for human body to avoid 
potential side effects and to be useful for treatment of small tumors;[11] second, they 
should be close to superparamagnetic (SPM) with low magnetostatic interactions to 
avoid agglomeration;[14,15] and third, they should be biocompatible with low 
cytotoxicity.[16-19]  
Iron oxide NPs are the most commonly used materials in magnetic hyperthermia 
because of their low toxicity.[20-23] Other ferrite NPs such as manganese ferrite, and 
more recently, zinc ferrite have also been explored due to their high magnetization 
among the ferrite family and stability against oxidation.[24,25] Relatively high SLP 
values have been achieved by these NPs.[26] However, further increasing the SLP by 
increasing the saturation magnetization (MS) would be futile. Although a high MS is 
beneficial for increasing SLP, high MS materials are typically metallic and face stability 
and toxicity issues in physiological environment.[21] An alternative approach to 
maximizing the SLP is to tune the effective anisotropy of the NPs. For example, shape 
anisotropy can be used to increase SLP of iron oxide nanocubes.[20] Very large SLP has 
been obtained by tuning the anisotropy of NPs through hard-soft exchange-coupled 
core/shell NP approach.[27] However, they were achieved at high field amplitude and 
frequency values unsuitable for clinical applications.[27]   
In this work, we report the design and synthesis of monodisperse SPM NPs with 
maximized SLP and intrinsic loss power (ILP) at different field parameters. ILP is 
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defined as SLP/H2f under linear response theory to compare the performance of NPs 
measured under different field parameters.[28] We first show that SLP can be maximized 
at H = 33 kA/m and f = 380 kHz, by alloying of hard cobalt ferrite and soft manganese 
ferrite to make CoxMn(0.3-x)Fe2.7O4, and tuning the size and composition of the mixed 
ferrite NPs. Unlike the core/shell approach, alloying allows convenient control of the 
effective anisotropy independent of NP size. A thin silica shell coating renders water-
solubility and bio-functionality.[22] 22 nm Co0.03Mn0.28Fe2.7O4/SiO2 NPs reach a SLP 
value of 3417 W/gmetal. We further optimize the composition of biocompatible ZnxFe3-
xO4 NPs for enhanced SLP under clinically safe field parameters (the product of field 
amplitude and frequency Hf < 5109 A/(ms)). The Zn0.3Fe2.7O4 NPs achieved SLP and 
ILP values of 1010 W/gmetal and 15.7 nHm
2/kg at H = 13 kA/m, 500 W/gmetal and 26.8 
nHm2/kg at 7 kA/m, and 282 W/gmetal and 59.9 nHm
2/kg at 3 kA/m, respectively (f = 
380 kHz). Zn0.3Fe2.7O4/SiO2 NPs show no cytotoxicity after 48 hrs at concentrations up 
to 500 µg/ml. Using the optimized biocompatible NPs, we achieved comparable 
temperature rise with significant decrease in dosage in a model mimicking bone tumor 
hyperthermia.[29,30] Cellular hyperthermia using 300 µg/ml Zn0.3Fe2.7O4/SiO2 NPs 
resulted in >89% cell death upon 10 min exposure to AC field of H= 13 kA/m and f = 
380 kHz. Our designed biocompatible NP with maximized SLP and ILP provide a 
pathway towards targeted magnetic hyperthermia treatment of small tumors and 
metastases[11], and rapid remote neural stimulation.[4]  
The mechanism of heat loss in magnetic hyperthermia is the energy dissipated 
during the magnetization reversal, and is therefore proportional to the product of the 
area of the AC magnetic hysteresis loop and the frequency.[31] An estimate of the upper 
limit of achievable SLP for ferrite NPs can be done as follows: 𝑆𝐿𝑃 = 
4𝜇0𝑀𝑆𝐻𝑚𝑎𝑥

𝑓, 
where 𝑀𝑆 is the saturation magnetization, 𝐻𝑚𝑎𝑥 the amplitude of the magnetic field, 
 the mass density of the NPs and 𝑓 the frequency .  is a dimensionless factor 
describing the deviation from a square hysteresis, which is related to the degree of 
alignment, and should also dependent on the types of effective anisotropy (uniaxial vs 
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cubic) and inter-particle interactions. Using  =1 for aligned Stoner-Wohlfarth particles 
with uniaxial anisotropy, 𝑀𝑆 ~ 480 kA/m, 𝐻𝑚𝑎𝑥  = 33 kA/m,  ~ 5 g/cm
3 and f =380 
kHz, SLP is estimated to be ~ 5000 W/gNP or ~ 7000 W/gmetal. Any value higher than 
that is likely non-physical. For completely random ensembles,  is reduced to 0.39.[31] 
Note here the optimal AC coercivity (𝐻𝑐) should be ~ 0.8𝐻𝑚𝑎𝑥. The AC hysteresis 
area is maximized this way despite the fact that a fraction of the NPs cannot be 
switched[31].  as high as 0.46 has been reported for magnetosomes aligned in an 
external field.[32] Thus the limit of SLP for any ferrite NPs at a field of 33 kA/m and 
380 kHz is about ½*7000 ~ 3500 W/gmetal.  
How can we then tune the properties of NPs to approach the theoretical limits? The 
key is to engineer the anisotropy energy barrier for magnetization reversal to match a 
specific field amplitude and frequency for a particular application.[4,15-18] According to 
the Stoner-Wohlfarth model,[33] the anisotropy barrier is proportional to KuV, where Ku 
is the uniaxial anisotropy constant and V is the volume of the magnetic grain, two 
critical parameters that can be tuned to maximize SLP. Ku and V together determine the 
temperature and frequency dependent coercivity ( 𝐻𝑐 ), and the shape of the AC 
hysteresis loop. Generally, at optimized effective anisotropy, a large NP size is 
preferred since MS increases slightly with increasing size, as long as it is not too large 
to accommodate multi-domain states which reduce 𝐻𝑐. Practically, the NPs should be 
kept nearly SPM to avoid dipole interaction induced agglomeration. We therefore adopt 
the following strategy to maximize SLP at clinically relevant field parameters: 1. Use 
soft ferrite Mn0.3Fe2.7O4 as a starting material to find the largest size for high SLP 
without agglomeration, as magnetostatic interactions are dependent on 𝑀𝑆V ; 2. With 
size optimized, tune the effective anisotropy to control the barrier of magnetization 
reversal, by alloying of magnetically hard cobalt ferrite with soft manganese ferrite to 
maximize SLP. Since MnFe2O4 has a magnetocrystalline anisotropy constant of 3.0×
103 J/m3, while that of CoFe2O4 is 2.0×105 J/m3, the anisotropy of the mixed ferrite 
will be very sensitive to the amount of cobalt alloying. At a field of 33 kA/m and 380 
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kHz, the SLP is maximized by tuning the alloy composition of CoxMn0.3-xFe2.7O4. One 
should aim for a room temperature anisotropy field slightly higher than the field 
amplitude to achieve the highest SLP.[31] The metal composition is limited to 
(Co+Mn):Fe = 1:9 to minimize potential toxicity; 3. Maximize SLP and ILP at field 
parameters below the clinical safety limit (f = 380 kHz, H  13 kA/m and Hf < 5109 
A/(ms)). As the anisotropy field of magnetite is larger than the field amplitude, alloying 
with a soft ferrite such as MnxFe3-xO4 is needed. For future in vivo applications, however, 
we choose zinc ferrite due to its bio-compatibility. Stoichiometric ZnFe2O4 is 
antiferromagnetic with low magnetization, while non-stoichiometric ZnxFe3-xO4 is a 
soft ferrite with MS moderately higher than that of Fe3O4 at low Zn content.
[25] We thus 
tune its composition to maximize SLP and ILP at field amplitudes smaller than 13 kA/m.  
 
All types of magnetic cores were synthesized by a modified one-pot thermal 
decomposition method.[12,34] These NPs are monodisperse with narrow size distribution, 
as observed from transmission electron microscopy (TEM) images. Fig. 1(a) is the TEM 
image of 22 nm Mn0.3Fe2.7O4 NPs. NPs show well-defined facets, with polyhedral shape. 
In our experiments, NPs from 7 nm up to 22 nm were investigated (Fig. S1), below 
which the NPs show SPM behavior. When the sizes are larger than 22 nm, Mn0.3Fe2.7O4 
NPs become ferromagnetic and tend to agglomerate in the solution due to strong 
magnetostatic interactions. Therefore, they are excluded from further investigations. A 
silica shell was coated by reverse microemulsion method.[35] The TEM image of the 22-
nm Mn0.3Fe2.7O4/SiO2 NPs is shown in Fig. 1 (b). The silica shells were kept thin with 
a thickness of 4-5 nm to minimize possible temperature gradient in AC field heating.[22] 
The silica coating makes the NPs hydrophilic, leading to aqueous dispersions stable for 
years without agglomeration (Fig. S2(a)). As shown in Fig S2(b), the zeta-potential of 
the NPs is about -30 mV. Negative charges on NP surface produces sufficient repulsive 
force to balance the magnetically induced attractive force to keep them from 
aggregation. 
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Within the core size range of 7 nm to 22 nm, the SLP of an aqueous dispersion of 1 
mg/ml Mn0.3Fe2.7O4/SiO2 NPs increases monotonically with increasing NP size, under 
an AC field of 33 kA/m and 380 kHz. The temperature change T vs time curves 
(heating curves) are plotted in Fig. 1 (c), where TT(t)-T0; T(t) is the temperature at 
time t and T0 is ambient temperature. From the heating curves, SLP vs size can be 
extracted using the Box-Lucas fitting known to give reliable SLP values,[36-39] and 
plotted in Fig. 1(d). The contribution from pure water under identical conditions was 
also measured and subtracted as the background. As can be seen from Fig. 1(c), the 
heating curve shows a negligibly small slope for 7 nm NPs, suggesting that 7 nm NPs 
can hardly heat in such a field; while 10 nm NPs start to heat with a low SLP of 164 
W/gmetal. Towards the other end of the size range, the SLP values for 18-nm NPs are 
much higher, reaching 1140 W/gmetal while 22-nm NPs have the highest value of 2278 
W/gmetal. This can be understood since larger NPs have higher energy barriers for 
magnetization reversal, thus the area of the AC hysteresis loop will be larger. In Fig. 
1(d), the red line is a cubic fitting of SLP as a function of NP diameter d. A reasonable 
agreement between the fitting and experimental data is found, suggesting that SLP is 
proportional to the NP volume.  
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Figure 1. Typical TEM images of (a) 22 nm Mn0.3Fe2.7O4 NPs, (b) 22-nm 
Mn0.3Fe2.7O4/SiO2 NPs, (c) Heating curves of aqueous solutions of Mn0.3Fe2.7O4/SiO2 
NPs (1 mgNPs/ml) with core sizes from 7 nm to 22 nm; and(d) Size dependence of SLP 
under the AC field of 380 kHz, 33 kA/m. 
Since there is an upper size limit due to agglomeration, as discussed earlier, an 
alternative approach to enhancing SLP is to increase the effective magnetic anisotropy, 
while fixing the NP size to 22 nm. We realize anisotropy tuning by cobalt alloying to 
produce mixed ferrites CoxMn(0.3-x)Fe2.7O4. Compared to earlier reported core/shell 
approach,[27] cation alloying possesses distinct advantages: one pot synthesis with high 
reproducibility, and the ability to tune anisotropy parameters independent of size.  
It is found that a small percentage of Co alloying (i.e. a moderately larger anisotropy) 
is optimum for maximizing SLP. The alloy composition (x~0-0.08) was controlled by 
varying the ratio of Co to Mn precursors. For example, Co0.01Mn0.29Fe2.7O4 NPs were 
synthesized by mixing Co, Mn and Fe precursors with the molar ratio of 0.01:0.29:2.7. 
The atomic ratio of Co:Mn:Fe measured by inductively coupled plasma atomic 
emission spectroscopy (ICP-AES) is 0.27:8.2:91, indicating that the composition of the 
final product replicates the precursor ratio. The magnetic hysteresis loops of CoxMn(0.3-
x)Fe2.7O4 NPs (x~0-0.03) measured at 300 K and 10 K are shown in Figure 2 (a) to (c). 
All NPs are SPM at 300 K, while exhibiting hysteresis at 10 K. The 10 K coercivity 
increases rapidly with increasing Co content, from 27.9 kA/m at x= 0.01 to 46.6 kA/m 
at x= 0.03. With Co alloying (x~0-0.03), the MS barely changes. The MS of Mn0.3Fe2.7O4 
NPs is 410 kA/m at 300 K, comparable to the bulk value of 446 kA/m, suggesting 
excellent crystallinity of the NPs. As shown in Fig. 2(d), the anisotropy constant Ku, 
estimated from low temperature coercivity HC and MS, increases monotonically with 
increasing Co concentration. With just 1 at% of Mn substituted by Co (x = 0.03), Ku 
increases by 300% from 9×103 J/m3 to 2.8×104 J/m3. The SLP (Fig. 2(f)), extracted 
from the heating curves (Fig. 2(e)) measured at H = 33 kA/m and f = 380 kHz, first 
increases with increasing Co concentration, showing a peak at x=0.03, then decreases 
with further increasing the Co amount. This is understood since increasing effective 
anisotropy increases the energy barrier for magnetization reversal, and thus the area of 
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the AC hysteresis loop initially increases. However, with further increasing anisotropy, 
the field amplitude is insufficient to saturate the magnetization at the operating 
frequency, resulting in minor hysteresis loops with decreased area. The maximum SLP 
is measured to be 3417 W/gmetal for x= 0.03, which is more than 50% higher than that 
for the same sized Mn0.3Fe2.7O4. This value is close to the theoretical limit of SLP for 
ferrite NPs, with an  value of 0.49. This is higher than  = 0.39 for a random ensemble. 
We suggest that the higher  not only reflects a certain degree of alignment due to dipole 
interactions, but also results from an effective anisotropy type close to cubic instead of 
uniaxial (𝑀𝑟/𝑀𝑆= 0.62 and 0.7, for x = 0.02 and 0.03, respectively, as extracted from 
Fig. 2).  We further note that for the sample with maximized SLP, the estimated room 
temperature anisotropy field HK is ~ 36 kA/m (see Table 1 of Supporting Information, 
SI), slightly higher than the applied field of 33 kA/m.  
 
 
 
 
 
 
 
 
 
Figure 2. The magnetic hysteresis loops of as-synthesized 22 nm CoxMn(0.3-x)Fe2.7O4 
NPs with (a) x=0.00, (b) x=0.02, (c) x=0.03, measured at 10 K and 300 K, respectively. 
(d) Anisotropy constant Ku at 10 K for CoxMn(0.3-x)Fe2.7O4 NPs as a function of x; (e) 
Heating curves of aqueous solutions of CoxMn(0.3-x)Fe2.7O4/SiO2 NPs (1 mgNPs/ml); and 
(f) Composition dependence of SLP under the AC field of 380 kHz, 33 kA/m. 
 
In general, SLP values increase with increasing frequency and amplitude of AC 
fields. However, for clinical hyperthermia applications, there is a safety limit on the 
product of field frequency and amplitude typically taken to be Hf =5109 A/(ms).[40-42] 
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Anisotropy optimized to achieve maximum SLP at high fields will not be optimal for 
clinically relevant low fields. Fig. S5(a) shows the heating curves of 22-nm 
Co0.03Mn0.27Fe2.7O4/SiO2 NP aqueous dispersion (1 mgNPs/ml) under the AC field of 
380 kHz with different field amplitudes. As calculated from the heating curve shown in 
Fig. S5(a) (see SI), the SLP at H =13 kA/m decreases to just 266 W/g, and further 
decreases to 40 W/g at 7 kA/m. To achieve large SLP and ILP at fields smaller than 13 
kA/m (Hf < 5109 A/(ms)), a softer material with an anisotropy field comparable to the 
field amplitude is needed. For clinical applications, we resort to non-stoichiometric zinc 
ferrite NPs for their biocompatibility and low anisotropy.[24] It is known that the MS of 
zinc ferrite is highly sensitive to Zn content, with ZnFe2O4 being antiferromagnetic if 
Zn2+ ions occupy the A-site of the spinel lattice only.[43] One can tune the MS and 
anisotropy by varying the Zn: Fe ratio. Fig. 3(a) shows the composition dependence of 
room temperature MS in ZnxFe3-xO4 NPs.  It can be seen that MS increases first 
monotonically with increasing x, and reaches a maximum of 458 kA/m at x =0.3, 
comparable to zinc ferrite synthesized by other methods.[44-46] Fig. 3(b) shows the 
composition dependence of anisotropy Ku measured at 10 K, being nearly constant 
below x=0.3 and decreases with further increasing x. The room temperature HK is 
estimated to be 18.5 kA/m (see SI), suggesting an AC HC of 9.2 kA/m, which is close 
to the optimal value for the applied field H= 13 kA/m, leading to nearly maximized AC 
hysteresis area and thus SLP. The heating performance of 22 nm Zn0.3Fe2.7O4/SiO2 NPs 
at varying field amplitudes were studied in detail. Fig. S5(b) shows heating curves of 
Zn0.3F2.7O4/SiO2 in the AC field of 380 kHz with varying amplitudes, and SLP as a 
function of field is plotted in Fig. 3(c). Comparing to Co0.03Mn0.27Fe2.7O4/SiO2, 
Zn0.3Fe2.7O4/SiO2 NPs exhibit much higher SLP at fields lower than 13 kA/m (Hf 
=4.9109 A/(ms), within the clinical safety limit). SLP is 1010 W/gmetal at H = 13 kA/m. 
Achieving SLP > 1000 W/g at clinically safe field parameters is significant, since it 
would allow sufficient heating for targeted treatment of small tumors and metastases, 
at low NP concentration achievable through antibody targeting.[47] To compare with 
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other NPs, ILP is calculated and plotted in Fig. 3(d). ILP is 15.7 nHm2/kg at H = 13 
kA/m, a value significantly higher than that of NPs synthesized previously.[48] As can 
be seen from fig. 3(d), ILP of Zn0.3Fe2.7O4 NPs reaches 26.8 nHm
2/kg at 7 kA/m (SLP 
= 500 W/gmetal). The  values are 0.37 and 0.34 for H = 13 and 7 kA/m, respectively, 
close to the theoretical value of 0.39 for a completely random ensemble. It is clear that 
SLP does not scale with H2 as predicted by the linear response theory or ILP would be 
a constant. As a comparison, bacteria magnetosomes are reported to have a SLP of 960 
W/gNPs and ILP of 23.4 nHm
2/kg at 410 kHz and 10 kA/m.[32] However, one should 
note that these values were obtained by aligning the NPs in an external field. Without 
field alignment, the obtained SLP is expected to be lower by a factor of three.[32] While 
the SLP increases monotonically with increasing field for both samples as seen in Fig. 
3(c), the field dependence shows different behavior. Co0.03Mn0.27Fe2.7O4 NPs have very 
low initial SLP which increases slowly with field at H < 13 kA/m. This is because the 
field amplitude of 13 kA/m is insufficient to saturate the magnetization of 
Co0.03Mn0.27Fe2.7O4 NPs due to their relatively large anisotropy field. The AC hysteresis 
is expected to be nearly linear in field with very small opening. On the other hand, SLP 
increases initially rapidly below 18 kA/m then slowly for Zn0.3Fe2.7O4, as its anisotropy 
field is found to be 18.5 kA/m.   
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Figure 3. Composition dependence of (a) saturation magnetization MS, measured at 10 
and 300 K; and (b) anisotropy constant Ku at 10 K, for ZnxFe3-xO4 NPs. (c) Field 
dependence of SLP for Zn0.3Fe2.7O4/SiO2 and Co0.03Mn0.27Fe2.7O4/SiO2 NPs, (d) Field 
dependence of ILP for Zn0.3Fe2.7O4/SiO2 and Co0.03Mn0.27Fe2.7O4/SiO2 NPs. 
In clinical hyperthermia applications, the contribution to heating due to physical 
rotation of NPs (Brownian relaxation) may be hindered in biological environment, e.g. 
in NPs embedded in bone cement. To investigate the realistic heating performance, we 
studied AC field heating of NP dispersions in water/glycerol mixture with different 
glycerol concentration up to 80 vol%. As can be seen in Fig. S10, SLP decreases with 
increasing glycerol concentration at all field values studied. At 80 vol% glycerol, the 
SLP ranges from 50% (at 3 kA/m) to 70% (at 18 kA/m) of the values for aqueous 
solutions. The reduction is primarily due to the high viscosity of glycerol, which is 60 
times that of water at room temperature.[49] The high viscosity of the glycerol solution 
hinders the rotation of the NPs, making Brownian motion ineffective in contributing to 
AC field heating. However, it is clear that the dominating contribution to hysteresis loss 
is the Néel relaxation, as more than 50% of the heating performance is retained for the 
most viscos sample. This enables high heating of NP bone cement as discussed in the 
following section.       
Surgical resection combined with chemo- and radiotherapy has been a clinical gold 
standard for the treatment of bone tumors. However, the patients are more likely to 
experience a tumor recurrence due to the bone microenvironment-associated tumor 
resistance to chemo- and radiotherapy, or inadequate surgical margins. Targeted thermal 
therapy of bone tumors become attractive because of its high selective damage of tumor 
tissue and repeatability.[50] We use bone cement containing 1 wt% Zn0.3Fe2.7O4 NPs for 
local hyperthermia experiments. A piece of pig rib with a hole 6.0 mm in diameter and 
6.0 mm in length were filled with the magnetic cement, and exposed to an AC field of 
380 kHz and 13 kA/m, as shown in Fig. 4 (a). The surrounding of the bone was water-
cooled at 37 C to mimic cooling by blood vessels. The temperature rise of the pig rib 
was recorded by both a high-resolution infrared (IR) camera and a fiber optic probe. It 
can be seen that the temperature of the magnetic cement rises rapidly to the therapeutic 
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threshold required for cancer hyperthermia (T >42 °C). The center of cement reaches 
50 °C within 1 minute; and the temperature of entire cement rises to above 50 °C within 
3 min. When the heating time is up to 30 min, the cement is heated to 70 °C, while the 
region 25 mm away from the center is above 46 °C. In Fig. 4 (a), the red dots represent 
the region with the temperature at the therapeutic threshold of 42 °C. With increasing 
exposure time, the region with temperature > 42 °C expands. After 25 min, the 
temperature of the entire bone is over 42 °C. As a comparison, in a previous study,[51] 
bone cement containing 60 wt% of magnetic materials was used to reach similar 
temperature change at a maximum AC field of 100 kHz and 23.9 kA/m. A significant 
reduction in dosage afforded by the high SLP of our optimized bio-compatible NPs can 
not only minimize any potential toxicity, but also preserve the mechanical integrity of 
the bone cement. 
 
Two types of NPs, 22-nm Co0.03Mn0.27Fe2.7O4/SiO2 and Zn0.3Fe2.7O4/SiO2, were 
tested for hyperthermia killing of Osteosarcoma MG-63 cells. Cell apoptosis was 
examined by a flow-cytometry-based annexin-V fluorescein isothiocyanate (see SI), as 
shown in Fig. 4 (b) to (e), respectively. Cells without NPs and with NPs but no AC field 
exposure were used as control. 1 × 104 MG-63 cells and Co0.03Mn0.27Fe2.7O4/SiO2 NP 
solution with a concentration of 25 g/ml were exposed to an AC magnetic field of 380 
kHz, 33 kA/m for 3 min. The percentage of the early and late apoptotic cells (i.e. cell 
death) is 81% in total, similar to values reported previously using a dosage of 50 
gNPs/ml at 37.4 kA/m and 500 kHz  (Hf  value 1.5 times higher).[16] To test the 
performance of Zn0.3Fe2.7O4/SiO2 NPs, a concentration of 300 gNPs/ml were used.  
Exposure to an AC field of H = 13 kA/m for 10 min resulted in 89% cell death, where 
the early apoptotic cells was 79.35% and late apoptotic cells 9.83%. It should be 
emphasized that all hyperthermia treatments in our studies were performed on adherent 
cells. Hyperthermia on suspended cells may overestimate cell death, as cells would be 
inevitably injured during the digestive process.[18,39,52] Since adherent cells more closely 
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simulate cells in vivo than suspended cells, our reported values should be more relevant 
in guiding clinical applications.  
 
 
 
 
 
 
 
 
 
 
Figure 4. (a) Infrared Photos of the bone heated under the field of 380 kHz, 13 kA/m; 
Apoptosis assay fluorescence from Annexin V and PI uptake by the MG-63 cells were 
monitored by flow cytometry. (b) MG-63 cells without NPs used as Control group. (c) 
MG-63 cells with NPs but not heated used as the second Control group. (d) MG-63 
cells incubated with 25gNPs/ml Co0.03Mn0.27Fe2.7O4 /SiO2 NPs heated under the AC 
field of 380 kHz, 33 kA/m (e) MG-63 cells incubated with 300 gNPs/ml Zn0.3Fe2.7O4 
/SiO2NPs heated under the AC field of 380 kHz, 13 kA/m. 
Cytotoxicity of different types of NPs to cells was also measured and compared.  
The viability of the MEF and MG-63 cells was determined by CCK-8 assay after 
incubation with various concentrations of NPs (Zn0.3Fe2.7O4/SiO2, Fe3O4/SiO2, and 
Mn0.3Fe2.7O4/SiO2) for 24 and 48h. Cells without NPs were used as control groups. As 
shown in Fig. 5, the cytotoxicity is the lowest for Zn0.3Fe2.7O4/SiO2 and highest for 
Co0.03Mn0.27Fe2.7O4/SiO2, with Fe3O4/SiO2 in between. In the case of Zn0.3Fe2.7O4/SiO2, 
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up to the concentration of 1000 µg/ml, the cell viability shows no significant difference 
(P > 0.05) from the control groups after incubation for 24h. Though at 700 and 1000 
g/ml after incubation for 48 h, viability of cells with Zn0.3Fe2.7O4/SiO2 is lower than 
that of control groups, it is still above 75% for MEF and above 73% for MG-63 cells. 
For MEF Incubated with Fe3O4/SiO2 NPs at concentration higher than 500 g/ml at 
both incubation time of 24 and 48 h, cell viability is lower than that of the control 
sample, while Fe3O4/SiO2 shows cytotoxicity in MG-63 starting at 300 g/ml upon 
incubation for 48 h. As for Co0.03Mn0.27Fe2.7O4/SiO2, cytotoxicity is observed at 
concentration above 100 g/ml, regardless of cell lines and incubation time. At the 
highest concentration of 1000 g/ml and 48 h, cell viability is even as low as 9.48%. 
 
 
 
 
 
 
 
 
Figure 5. The viability of the MEF and MG-63 cells determined by CCK-8 assay 
after incubation in NP solutions with various concentrations for 24h (a,b) and 48h (c,d) . 
 
In summary, we have designed and synthesized two types of magnetic/silica 
core/shell NPs. CoxMn0.3-xFe2.7O4/SiO2 with Co concentration of x=0.03 results in 
maximized specific loss power of 3417 W/g at an AC field of 33 kA/m and 380 kHz; 
and biocompatible Zn0.3Fe2.7O4/SiO2 achieved SLP of 1010 W/g at a field of 13 kA/m 
 15 
 
and 380 kHz. The intrinsic loss power ranges from 15.7 to 59.9 nHm2/kg as the field 
decreases from 13 to 3 kA/m for the latter. We further demonstrate efficient 
hyperthermia using Zn0.3Fe2.7O4 NPs in magnetic cement for bone tumor, incorporating 
ultralow dosage of just 1 wt% of nanoparticles. Zn0.3Fe2.7O4 NPs also demonstrate good 
hyperthermia performance to kill cancer cells. Zn0.3Fe2.7O4 NPs show excellent 
biocompatibility, exhibiting no cell cytotoxicity at concentrations up to 500 µg/ml 
within 48 hrs. Our work provides a guidance for design of NPs with appropriate 
magnetic properties for maximized heating power at any field parameters, and 
conversely, given a particular NP type, choice of field parameters leading to maximized 
heating power. Furthermore, our biocompatible NP platform with greatly enhanced AC 
field heating at low field amplitudes are promising for targeted hyperthermia of small 
tumors and metastases. Further in vivo studies are needed to show the therapeutic effect 
of these optimized nanoparticles.  
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Methods 
1. Experimental Methods 
Synthesis of CoxMn(1-x)Fe2O4 nanoparticles 
A series of CoxMn(0.3-x)Fe2.7O4 mixed ferrite NPs of different sizes and 
composition were synthesized by a one-pot solution method through thermal 
decomposition of a mixture of metal acetylacetonates with surfactants in a high-boiling 
point organic solvent. Iron(III) acetylacetonate (2 mmol), manganese(II) 
acetylacetonate and cobalt(II) acetylacetonate (total 1 mmol), 1,2-hexadecanediol, oleic 
acid (3 mmol), oleylamine (3 mmol), and 20 mL benzyl ether were mixed and 
magnetically stirred under a flow of nitrogen. The mixture was first heated to 393 K for 
30 minutes to remove the low boiling point solvent, then to 473 K and kept at that 
temperature for 1 hour. At a ramping rate of 10 K min-1 the solution was further heated 
to reflux (~573 K) and kept at 573 K for 1 hour. The solution was cooled down to room 
temperature by removing the heat source. The solution was treated with ethanol in the 
air atmosphere. CoxMn(1-x)Fe2O4 NPs were precipitated from the solution, centrifuged 
to remove the solvent, and redispersed in hexane. The size of nanoparticles was tuned 
by the ratio of oleic acid to metal precursors.[12]  
Synthesis of Zn0.3Fe2.7O4 nanoparticles  
Under a gentle flow of Ar, Iron(III) acetylacetonate (2.7 mmol), zinc(II) 
acetylacetonate (0.3 mmol), sodium oleate (2 mmol) and oleic acid (4 ml) were mixed 
with benzyl ether (20 ml). The mixture was magnetically stirred under a flow of Ar and 
then heated to 393 K for 1 h. Under an Ar blanket, the solution was further heated to 
reflux (~573 K) and kept at this temperature for 1h. The mixture was then cooled down 
to room temperature by removing the heating mantle. The size of nanoparticles were 
tuned by controlling the heating rate during heating from 393 K to 573 K. 
Silica coating of magnetic NPs 
The silica shells were coated on the hydrophobic NPs via a reverse microemulsion 
method.[22,32] For 4-5 nm silica coating, 20 ml cyclohexane and 1.15 ml Igepal CO-520 
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were mixed and 20 mg magnetic NPs in 2 ml cyclohexane were added while stirring. 
0.15 ml ammonium hydroxide (28-30%) was then added, followed by 0.1 ml TEOS. 
The solution was stirred at room temperature for 24 h and the resulting magnetic 
NPs/SiO2 core/shell NPs were precipitated by adding ethanol and centrifugation. The 
collected particles were washed in ethanol and water twice and precipitated by 
centrifugation and finally redispersed in water. 
Characterizations 
A Hitachi H7650 (120kV) transmission electron microscope was used to characterize 
the size and morphology of the NPs. Energy dispersive X-ray spectroscopy and 
inductively coupled plasma atomic emission spectroscopy were employed to determine 
the composition. The magnetic hysteresis loops were measured using a Quantum 
Design Physical Property Measurement System model 6000. Hyperthermia 
performance of the NPs was investigated by a HYPER5 machine fabricated by MSI 
Company under an AC magnetic field with frequency of 380 kHz. The temperature 
change of the NP solution was monitored by a fiber optic probe. 
In vitro experiments 
Human osteogenic sarcoma MG-63 cells and mouse fibroblast cells (MEF) were 
purchased from the American Type Culture Collection. MG-63 cells were plated in 35-
mm culture dishes at 80% confluence (1×106 cells) with 2ml of DMEM/HIGH 
GLUCOSE medium containing 10% fetal bovine serum. The NP dispersion was added 
to culture dishes, and the samples were exposed to the AC magnetic field. Apoptotic 
cell was detected by a flow cytometer (Beckman coulter Ltd., USA). MEF cells were 
seeded in 96-well plates at a density of 5,000 cells per well. After incubation for 24 hr 
and 48 hr, the cell viabilities were determined by the standard Cell Counting Kit-8 
(CCK-8, Dojindo, Japan) assay. 
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1. Experimental Methods 
Synthesis of CoxMn(0.3-x)Fe2O4 nanoparticles 
A series of CoxMn(0.3-x)Fe2O4 mixed ferrite NPs of different sizes and composition 
were synthesized by a one-pot solution method through thermal decomposition of a 
mixture of metal acetylacetonates with surfactants in a high-boiling point organic 
solvent. Iron(III) acetylacetonate (2 mmol), manganese(II) acetylacetonate and 
cobalt(II) acetylacetonate (total 1 mmol), 1,2-hexadecanediol, oleic acid (3 mmol), 
oleylamine (3 mmol), and 20 mL benzyl ether were mixed and magnetically stirred 
under a flow of nitrogen. The mixture was first heated to 393 K for 30 minutes to 
remove the low boiling point solvent, then to 473 K and kept at that temperature for 1 
hour. At a ramping rate of 10 K min-1 the solution was further heated to reflux (~573 K) 
and kept at 573 K for 1 hour. The solution was cooled down to room temperature by 
removing the heat source. The solution was treated with ethanol in the air atmosphere. 
CoxMn(0.3-x)Fe2O4 NPs were precipitated from the solution, centrifuged to remove the 
solvent, and redispersed in hexane. The size of nanoparticles was tuned by the ratio of 
oleic acid to metal precursors. 
 
Synthesis of Zn0.3Fe2.7O4 nanoparticles  
Under a gentle flow of Ar, Iron(III) acetylacetonate (2.7 mmol), zinc(II) 
acetylacetonate (0.3 mmol), sodium oleate (2 mmol) and oleic acid (4 ml) were mixed 
with benzyl ether (20 ml). The mixture was magnetically stirred under a flow of Ar and 
then heated to 393 K for 1 h. Under an Ar blanket, the solution was further heated to 
reflux (~573 K) and kept at this temperature for 1h. The mixture was then cooled down 
to room temperature by removing the heating mantle. The size of nanoparticles were 
tuned by controlling the heating rate during heating from 393 K to 573 K. 
 
Silica coating of magnetic NPs 
The silica shells were coated on the hydrophobic NPs via a reverse microemulsion 
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method. For 4-5 nm silica coating, 20 ml cyclohexane and 1.15 ml Igepal CO-520 were 
mixed and 20 mg magnetic NPs in 2 ml cyclohexane were added while stirring. 0.15 
ml ammonium hydroxide (28-30%) was then added, followed by 0.1 ml TEOS. The 
solution was stirred at room temperature for 24 h and the resulting magnetic NPs/SiO2 
core/shell NPs were precipitated by adding ethanol and centrifugation. The collected 
particles were washed in ethanol and water twice and precipitated by centrifugation and 
finally redispersed in water. 
 
Characterizations 
A Hitachi H7650 (120kV) transmission electron microscope was used to characterize 
the size and morphology of the NPs. Energy dispersive X-ray spectroscopy and 
inductively coupled plasma atomic emission spectroscopy were employed to determine 
the composition. The magnetic hysteresis loops were measured using a Quantum 
Design Physical Property Measurement System model 6000. Hyperthermia 
performance of the NPs was investigated by a HYPER5 machine fabricated by MSI 
Company under an AC magnetic field with frequency of 380 kHz. The temperature 
change of the NP solution was monitored by a fiber optic probe. 
 
In vitro experiments 
Human osteogenic sarcoma MG-63 cells and mouse fibroblast cells (MEF) were 
purchased from the American Type Culture Collection. MG-63 cells were plated in 35-
mm culture dishes at 80% confluence (1×106 cells) with 2ml of DMEM/HIGH 
GLUCOSE medium containing 10% fetal bovine serum. The NP dispersion was added 
to culture dishes, and the samples were exposed to the AC magnetic field. Apoptotic 
cell was detected by a flow cytometer (Beckman coulter Ltd., USA). MEF cells were 
seeded in 96-well plates at a density of 5,000 cells per well. After incubation for 24 hr 
and 48 hr, the cell viabilities were determined by the standard Cell Counting Kit-8 
(CCK-8, Dojindo, Japan) assay. 
 23 
 
2. TEM Images of Mn0.3Fe2.7O4 and Mn0.3Fe2.7O4/SiO2 NPs with different sizes 
 
 
 
 
 
 
 
 
 
 
 
Figure S1. TEM images of Mn0.3Fe2.7O4 nanoparticles of (a) 7 nm (b) 10nm, (c) 16 nm, 
(d) 22 nm, (e) 16-nm Mn0.3Fe2.7O4/5-nm SiO2 NPs, (f) 22-nm Mn0.3Fe2.7O4/5-nm SiO2 
NPs 
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3. Long term stability of the NP dispersion 
a 
 
 
 
 
 
 
 
 
b     
 
    
 
 
 
Figure S2. (a) A photograph of CoxMn0.3-xFe2.7O4/SiO2 aqueous dispersions (10 
mgNPs 𝑚𝑙
−1), from left to right: x=0.00, x=0.01, x=0.02, x=0.03. The samples are 
stable for > 24 months with no precipitation, (b) z-potential curve of  
Co0.03Mn0.27Fe2.7O4/SiO2 nanoparticles. 
As shown in Fig S2(b), zeta potential of CoxMn0.3-xFe2.7O4/SiO2 NPs is about -30 
mV. Negative charges on NP surface produces sufficient repulsive force to balance the 
magnetically induced attractive force in water. 
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4. Synthesis of Zn0.3Fe2.7O4 NPs -Tuning of NP sizes by heating rate 
The sizes of Zn0.3Fe2.7O4 nanoparticles can be tuned by controlling the heating rate 
during the synthesis from 393 K to 573 K. The heating rate of 10 K/min leads to 22-nm 
ZFO NPs, and 6 K/min results in 18-nm ZFO NPs. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3. TEM images of (a) Zn0.3Fe2.7O4 NPs, (b) Zn0.3Fe2.7O4@SiO2 NPs 
synthesized with the heating rate of 6 K/min, (c) Zn0.3Fe2.7O4 NPs, (d) 
Zn0.3Fe2.7O4@SiO2 NPs synthesized with the heating rate of 10K/min. 
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5. Measurement of magnetic anisotropy  
Saturation magnetization MS of NPs was measured by an EV-9 vibrating sample 
magnetometer. NPs were embedded in non-magnetic cement (purchased from Quantum 
Design company). The mass of organic coating on NPs was measured by 
thermogravimetric analysis. The net mass of NPs was used to determine the saturation 
magnetization. The effective magnetic anisotropy Ku was estimated from MS and HC at 
10 K, using 𝐾𝑢~𝑀𝑠𝐻𝑐. 
 
Table 1. Saturation magnetization MS measured at 10 and 300 K, coercitivity HC 
measured at 10 K, anisotropy Ku at 10 K, and estimated anisotropy field HK at 300 K of 
CoxMn0.3-xFe2.7O4 NPs. Ku increases with increasing Co alloying concentration x.  
 
CoxMn0.3-xFe2.7O4  x =0.00 x =0.01 x =0.02 x =0.03 
MS (kA/m) at 10 K 468.4 466.9 465.8 465.3 
MS (kA/m) at 300 K 410.5 409.5 408.9 408.4 
HC (kA/m) at 10 K 15.0 27.9 37.2 46.6 
Ku  (104 J/m3) at 10 K 0.9 1.66 2.2 2.8 
HK (kA/m) at 300 K 11.5 21.5 28.7 35.9 
     
Table 2. Saturation magnetization MS measured at 10 and 300 K, coercitivity HC 
measured at 10 K, anisotropy Ku at 10 K, and estimated anisotropy field HK at 300 K of 
ZnxFe3-xO4 NPs. 
 
ZnxFe3-xO4 x =0.0 x =0.2 x =0.3 x =0.4 x =0.5 x =0.8 x =1.0 
MS (kA/m) at 10 K 461.7 506.8 526.8 511 505.3 316.1 171.7 
MS (kA/m) at 300 K 401.5 440.7 458.1 444.3 439.4 274.9 149.3 
HC (kA/m) at 10 K 28.2 25.3 24.6 23.1 20.8 18.7 18.1 
Ku  (104 J/m3) at 10 K 1.61 1.57 1.6 1.45 1.29 0.73 0.38 
HK (kA/m) at 300 K 21.3 19.1 18.5 17.4 15.7 14.1 13.7 
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HK at 300 K is estimated using the formula below to consider the thermal 
fluctuation of magnetic moment;  is taken to be 3 [S1] 
 
𝐾𝑢(𝑇 = 0)
𝐾𝑢(𝑇 = 300 𝐾)
= [
𝑀𝑆(𝑇 = 0)
𝑀𝑆(𝑇 = 300 𝐾)
]
𝛾
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6. Measurement of solution temperature for SLP determination  
The temperature of the solution was measured by a fiber optic thermometer at 
different locations of the vial. A schematic drawing of the measurement setup is shown 
in Fig. S4 (a). The heating curves for these locations are plotted in Fig. S4 (b). 
 
 
 
 
 
 
Fig. S4. (a) Schematic drawing of the measurement setup used in this work; (b) The 
heating curves measured at different locations (including outside the vial). 
 
As can be seen from Fig. S4(b), the temperature inside the vial is uniform, with 
negligible temperature difference for the probe located at the top, middle and bottom of 
the solution in the vial. All SLP reported were measured with the probe located at 
middle of the solution in the vial. Furthermore, the vial temperature, measured at the 
outer surface of the vial, is considerably higher than the ambient temperature, 
suggesting that the energy absorption by the container cannot be neglected. As can be 
seen from the heating curves for the probe located at the outer surface of the vial, the 
surface temperature change of the vial can reach 2/3 of the solution temperature change. 
For example, as the solution temperature increases by 60 C, the vial temperature can 
increase by 40 C. Therefore, we stress that measurements ignoring the energy 
absorption of the container tends to underestimate the SLP values. However, since most 
previous papers published SLP values without considering container absorption, in this 
paper all SLP values were calculated ignoring the vial absorption, for a fair comparison 
with published results. 
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7. AC filed heating curves for two type of NPs at different field amplitudes 
 
 
 
 
 
 
 
 
Figure S5. AC field heating of NPs measured by temperature vs time curves for (a) 
Co0.03Mn0.27Fe2.7O4/SiO2 NP and (b) Zn0.3Fe2.7O4/SiO2 NP aqueous dispersions (1 
mgNPs/ml) under an AC field of 380 kHz with different field amplitudes. 
 
 
 
 
 
 
 
 
 
 
Figure S6. AC field heating curve for Zn0.3Fe2.7O4/SiO2 NP aqueous dispersions (5 
mgNPs/ml) under an AC field of 3 kA/m and 380 kHz. The temperature change reaches 
40 C in 25 min, demonstrating the remarkable heating capability of this material at 
ultralow field. 
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8. Extraction of SLP  
For reliable extraction of SLP, all heating curves are fitted by the Box-Lucas 
formula ∆T =
𝑆𝑚
𝑘
(1 − 𝑒−𝑘(𝑡−𝑡0))[S2] with 𝑆𝑚 and k as the fitting parameters. 𝑆𝑚 is 
the initial slope of the heating curve, and k is a constant describing the cooling rate. SLP 
is then calculated as 𝑆𝐿𝑃 =
𝐶𝑣𝑆𝑚
𝜌𝑖
, where 𝐶𝑣 is the specific heat capacity of the solution 
taken to be 4.184 J/(gC), and 𝜌𝑖 is the mass concentration of the metal in the NP 
solution (e.g. for Fe3O4, 1 mgNPs/ml = 0.724 mgFe/ml).  
The reliability of the fitting is further verified by measuring the cooling curve 
directly (shown in Fig. S7(b)), from which k can be extracted independently using 
∆T = 𝑇0 + (𝑇 − 𝑇0)𝑒
−𝑘(𝑡−𝑡0). The difference is found to be smaller than 0.1%.  
 
 
 
 
 
 
 
 
Figure S7. (a) Experimental heating curve (black) and Box-Lucas fitting (red) of 
Co0.03Mn0.27Fe2.7O4/SiO2 NP solution exposed in the ac field of 380 kHz and 33 
kA/m,  (b)  Experimental cooling curve of NPs solution (black) and fitting curve 
using 𝑇(𝑡) = 𝑇0 + (𝑇 − 𝑇0)𝑒
−𝑘(𝑡−𝑡0) (red).  
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Figure S8. Examples of heating curve (black) and Box-Lucas fitting curve (red) of 
Co0.03Mn0.27Fe2.7O4/SiO2 NP solution exposed in the AC field of 380 kHz under 
different field amplitudes. 
 
 
 
 
 
 
 
 
 
 
 
Figure S9. Examples of heating curve (black) and Box-Lucas fitting curve (red) of 
Zn0.3Fe2.7O4/SiO2 NP solution exposed in the AC field of 380 kHz under different field 
amplitudes. 
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9. SLP and ILP of NPs in recent studies 
 
Sample 
SLP 
(W/gmetal) 
ILP 
(nHm2/kg) 
AC field Reference 
Multicore -Fe2O3 2000 4.6 700 kHz, 25 kA/m Ref. S3 
Zn0.4Co0.6Fe2O4/ 
Zn0.4Mn0.6Fe2O4 
3886 5.6 500 kHz, 37.3 kA/m Ref. S4 
Fe3O4 2452 5.6 520 kHz, 29 kA/m Ref. S5 
Fe3O4 1000 6.3 100 kHz, 40 kA/m Ref. S6 
Fe3O4 332 8.3 400 kHz, 10 kA/m Ref. S7 
magnetosomes 960 23.4 410 kHz, 10 kA/m Ref. S8 
Co0.03Mn0.27Fe2.7O4 3417 8.3 380 kHz, 33 kA/m This work 
Zn0.3Fe2.7O4 1010 15.7 380 kHz, 13 kA/m This work 
Zn0.3Fe2.7O4 500 26.7 380 kHz, 7 kA/m This work 
Zn0.3Fe2.7O4 282 59.9 380 kHz, 3 kA/m This work 
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10. Measurements of the SLP at different percentage of glycerol 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S10. AC field heating of NPs measured by temperature vs time curves for 
Zn0.3Fe2.7O4/SiO2 NP water/glycerol mixture dispersions (1 mgNPs/ml) (a) containing 
40% glycerol, (b) containing 80% glycerol, under an AC field of 380 kHz with different 
field amplitudes; (c) Field dependence of SLP for Zn0.3Fe2.7O4/SiO2 aqueous and 
water/glycerol mixture dispersions. 
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11. AC field induced cell apoptosis (cell death) with different exposure time 
The cell apoptosis for MG-63 cells incubated with ZFO NPs and exposed to an ac 
magnetic field with different exposure time, as shown in Fig.S11. In Fig S11 (c) to (f), 
the third quadrant demonstrates the early apoptosis of cell, and the fourth quadrant 
represents late apoptosis. The total cell apoptosis is the sum of early apoptosis and late 
apoptosis. The efficiency of cell apoptosis increases with increasing exposure time in 
AC magnetic field. In particular, the percentage of late apoptotic cells increases more 
prominently with increasing exposure time. Magnetic hyperthermia at ac field of 380 
kHz and 13 kA/m for 30 min leads to about 89% cell apoptosis.  
 
 
 
 
 
 
 
 
Figure S11. Apoptosis assay fluorescence from Annexin V and PI uptake by the MG-
63 cells were monitored by flow cytometry. (a)MG-63 cells without NPs used as a 
control group.(b) MG-63 cells with NPs but not exposed to ac field used as another 
control group; MG-63 cells incubated with 300 g/ml NPs heated under the ac field of 
380 kHz, 13 kA m-1 for (c) 5 min (d) 10 min (e) 20 min (f) 30 min. 
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